Integrated multi-omic profiling of human tumor-infiltrating T cells reveals cell-intrinsic regulators of T cell dysfunction that are missed by transcriptomic analyses alone, highlighting an additional layer of regulatory control.
Abstract
CD8⁺ T cells in solid cancers progressively lose anti-tumor activity, yet the cell-intrinsic mechanisms driving this loss of function remain incompletely defined. Here, we performed matched proteomic and transcriptomic profiling of dysfunctional and bystander CD8⁺ tumor-infiltrating T cells isolated from primary tumors of treatment-naïve non-small cell lung cancer patients. Proteomic analysis revealed widespread discordance with mRNA expression, with 8% of all quantified proteins displaying differential expression exclusively at the protein level. Genetic perturbation of such differentially expressed proteins identified the chromatin remodeler CHD4 and fatty acid synthase (FASN) as cell-intrinsic regulators of T cell function. CHD4 deletion resulted in altered gene-regulatory networks that promoted effector differentiation and enhanced cytokine production. In contrast, FASN deletion preserved mitochondrial fitness and sustained T cell functionality under chronic T cell receptor stimulation. Together, these findings demonstrate that proteomic profiling uncovers regulators of T cell functionality that are not apparent from transcriptomic analyses alone, highlighting an additional layer of regulatory control. One Sentence Summary Integrated multi-omic profiling of human tumor-infiltrating T cells reveals cell-intrinsic regulators of T cell dysfunction that are missed by transcriptomic analyses alone.
A comprehensive single-cell multiomic analysis of primary human T cells exposed to exosomes derived from 17 genomically diverse TNBC cell lines and 35 patient samples uncovered conserved and subtype-specific immunomodulatory programs induced by TNBC exosomes.
Sanam Rezaei Benam, S. Maleknia, Kent Williams et al.· Signal Transduction and Targ...· 0 citations
These findings identify a tumor-adapted MC state that orchestrates immune evasion and tissue remodeling during CRC progression, supporting the notion that MC are reprogrammed toward an immune-suppressive and pro-tumorigenic phenotype.
E. Putro, Alessia Carnevale, Caterina Marangio et al.· Cell Death & Disease· 0 citations
Integrative single-cell RNA sequencing analysis of publicly available datasets from non-small cell lung cancer and breast cancer is performed to systematically map transcriptional heterogeneity and regulatory networks within the TME, providing a systems-level framework of TME organization.
M. O. Odubote, Chiemeka Elochi Emeribe· bioRxiv· 0 citations
Immune checkpoint blockade elicits durable responses in a subset of patients with gastric cancer, yet the cellular programs underlying therapeutic divergence remain unclear. Using integrative single-cell transcriptomics of tumors from Immune Checkpoint Inhibitor (ICI)-treated patients, we resolved the CD8 + T-cell landscape associated with response. Therapeutic outcome reflected not only differences in state abundance but also functional reprogramming within shared states. Trajectory analysis revealed bifurcation of naïve CD8 + T cells into effector and exhaustion-prone branches that were differentially enriched between responders and non-responders. Inference of transcription factor activity revealed lineage-specific modules associated with these divergent fates. Further modeling of ligand-receptor pairs uncovered how signaling between myeloid and T cells changes during different responses. Together, these findings delineate a regulatory and intercellular framework characterizing CD8 + T-cell differentiation in gastric cancer and illuminate mechanisms of immune-state divergence during immunotherapy.
Ming-De Zang, Yi-Sa Xuan, Guanlin Li et al.· Biochemical and Biophysical...· 0 citations
This study proposes that PGCCs represent an immune-adaptive polyploid survival state in which inflammatory and ontogenetic pathways are repurposed to support immune evasion and tumor persistence and provides a framework for therapeutic strategies aimed at dismantling the PGCC reservoir and preventing tumor relapse.
O. Anatskaya, Alexander E. Vinogradov· International Journal of Mol...· 0 citations
The findings demonstrate that MCs exhibit distinct functional states in ESCC and regulate tumor progression and support their potential relevance in immunotherapy.
Yiren Huang, Zheyi Chen, Bingqian Zhou et al.· Frontiers in Immunology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.